Six leaders working on LGBTQ+ inclusion in biopharmanews2026-06-15T14:00:22+00:00June 15th, 2026|Endpoints News|
Endpoints Women in Biopharma: Nominate for 2026news2026-06-09T14:16:22+00:00June 9th, 2026|Endpoints News|
The R&D 15: How pharma’s top companies spent, won and lost on drug researchnews2026-04-30T11:15:51+00:00April 30th, 2026|Endpoints News|
Endpoints 100 survey 2025: Biotech CEOs are feeling more upbeatnews2025-12-11T12:00:03+00:00December 11th, 2025|Endpoints News|
Ex-Lilly Diabetes leaders hunt for new obesity drugs at VC firmnews2025-11-10T14:00:26+00:00November 10th, 2025|Endpoints News|
Special report 2025: Meet 20 women reshaping the future of biopharmanews2025-10-07T14:20:48+00:00October 7th, 2025|Endpoints News|
How past Endpoints 11 winners fared during 2025’s biotech downturnnews2025-09-03T11:00:44+00:00September 3rd, 2025|Endpoints News|
Who are the women reshaping biopharma R&D? Nominate them for Endpoints’ annual reportnews2025-06-09T11:00:36+00:00June 9th, 2025|Endpoints News|
Biopharma leaders carving a path for the industry’s LGBTQ+ communitynews2025-06-06T11:10:22+00:00June 6th, 2025|Endpoints News|
Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontentnews2025-05-20T11:00:54+00:00May 20th, 2025|Endpoints News|
